Skip to content

KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS · XNAS

CIK 1877184fmd_02CGF0537C7PWR3B9BMS4GBG2WManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: May 01, 2023 to Jul 31, 2026, 10 periods

Latest annual · FY2026

Millions
Total revenues
95
Gross profit
49
Operating income
(135)
Net income
(132)
Free cash flow
(117)

Latest quarter · Q1 FY2027

Millions
Total revenues
31
Gross profit
17
Operating income
(38)
Net income
(44)
Free cash flow
(41)

Daily close · KMTSIEX trades only

Nov 09, 2026 to Nov 11, 2026 · 3 sessions

31.61 USD

29.5030.0030.5031.0031.5032.00Nov 09, 2026Nov 10, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2026FY2025ChangeSource
Revenue$95.1 million$59.8 million+59%10-K 2026-07-14 · proof
Gross profit$48.9 million$24.2 million+101.8%10-K 2026-07-14 · proof
Operating income-$134.7 million-$106.4 million10-K 2026-07-14 · proof
Net income-$131.6 million-$113.8 million10-K 2026-07-14 · proof
Cash from operating activities-$81.7 million-$77.6 million10-K 2026-07-14 · proof
Free cash flow-$116.6 million-$100.5 million10-K 2026-07-14 · proof
Total assets$358.5 million$295.7 million+21.2%10-K 2026-07-14 · proof
Total liabilities$98.8 million$90.3 million+9.4%10-K 2026-07-14 · proof
Cash and cash equivalents$99.7 million$237.6 million-58%10-K 2026-07-14 · proof
What was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s revenue in fiscal 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported revenue of $95.1 million for fiscal 2026 (the year ended Apr 30, 2026), against $59.8 million the year before (+59%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s gross profit in fiscal 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported gross profit of $48.9 million for fiscal 2026 (the year ended Apr 30, 2026), against $24.2 million the year before (+101.8%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s operating income in fiscal 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported operating income of -$134.7 million for fiscal 2026 (the year ended Apr 30, 2026), against -$106.4 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s net income in fiscal 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported net income of -$131.6 million for fiscal 2026 (the year ended Apr 30, 2026), against -$113.8 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s cash from operating activities in fiscal 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported cash from operating activities of -$81.7 million for fiscal 2026 (the year ended Apr 30, 2026), against -$77.6 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s free cash flow in fiscal 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported free cash flow of -$116.6 million for fiscal 2026 (the year ended Apr 30, 2026), against -$100.5 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What are KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s total assets?
As of Apr 30, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported total assets of $358.5 million, against $295.7 million a year earlier (+21.2%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What are KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s total liabilities?
As of Apr 30, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported total liabilities of $98.8 million, against $90.3 million a year earlier (+9.4%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
What are KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s cash and cash equivalents?
As of Apr 30, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported cash and cash equivalents of $99.7 million, against $237.6 million a year earlier (-58%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:KMTS&period_type=annual&limit=5"

Information only, not investment advice.